Title: The liver steatosis severity and lipid characteristics in primary biliary cholangitis
Version: 1 Date: 15 Sep 2021
Reviewer:  Vik Meadows
Reviewer's report:
The authors present a succinct and direct story of how CAP analysis of steatosis and HDL can
be prognostic markers in PBC for cardiovascular co-morbidities. The authors have addressed
this reviewers comment and this manuscript would be a welcome addition to the field for
clinicians and researchers alike trying to discover new biomarkers/prognostic markers to prevent
co-morbidities in PBC patients.
Title: The liver steatosis severity and lipid characteristics in primary biliary cholangitis
Version: 1 Date: 15 Sep 2021
Reviewer:  Vik Meadows
Reviewer's report:
The authors present a succinct and direct story of how CAP analysis of steatosis and HDL can
be prognostic markers in PBC for cardiovascular co-morbidities. The authors have addressed
this reviewers comment and this manuscript would be a welcome addition to the field for
clinicians and researchers alike trying to discover new biomarkers/prognostic markers to prevent
co-morbidities in PBC patients.
Please review this paper.
user
Title: The liver steatosis severity and lipid characteristics in primary biliary cholangitis
Version: 1 Date: 15 Sep 2021
Reviewer:  Vik Meadows
Reviewer's report:
The authors present a succinct and direct story of how CAP analysis of steatosis and HDL can
be prognostic markers in PBC for cardiovascular co-morbidities. The authors have addressed
this reviewers comment and this manuscript would be a welcome addition to the field for
clinicians and researchers alike trying to discover new biomarkers/prognostic markers to prevent
co-morbidities in PBC patients.
assistant